Trial exclusion patterns Phase 2 and Phase 3 retatrutide trials commonly excluded participants with a history of pancreatitis, medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2 (MEN 2), severe gastroparesis, recent major cardiovascular events, severe kidney impairment, type 1 diabetes (in the obesity studies), and pregnancy or breastfeeding
Andrews PW, Bharwani A, Lee KR, Fox M, Thomson JA
How to Use GHK-Cu Serum For best results, follow this routine: Cleanse your face thoroughly Apply toner (optional) Use a few drops of GHK-Cu serum Follow with moisturizer Apply sunscreen in the morning Pro Tip: Avoid using copper peptides simultaneously with strong actives like Vitamin C or retinol to maintain effectiveness
and (5) you agree to indemnify and hold harmless the clinic and its providers from any adverse outcomes, including those that may arise from off-label use
The lack of success at Phase III was attributed to factors such as high baseline immunosuppressive therapy in patients and complex disease mechanisms in SLE, potentially limiting the application of Rituximab as a monotherapy in SLE (119)
